safety-lane.com 07105
chiropractic-lane.com
www.shopcbd-lane
NEWARK
Semaglutide helps more than weight loss
A new study by Novo Nordisk found that semaglutide, the compound that’s taken the world by storm as a weight loss drug in its blockbuster products Ozempic and Wegovy, also slows the progression of chronic kidney disease.
It was also found to reduce the risk of kidney failure, heart attack, stroke, and death in Type 2 diabetes patients. The findings from the long-term study, which yielded such good results that the company stopped it early, may revolutionize how doctors approach kidney disease.
via Blogger https://bit.ly/3VgGcLF
Recent Comments